Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FQP3H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,446
Award facts
- Contract value 100% obligated
- $101,445.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Biktarvy (50-200-25 mg tablets) in quantities of 30 units, with a ceiling value of $101,445.98. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to conclude by November 5, 2025, and performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's role in supplying essential pharmaceuticals to military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key participant in the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26FQP3H?
SPE2DR26FQP3H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FQP3H worth?
The government has obligated $101,446 on SPE2DR26FQP3H.
Is contract SPE2DR26FQP3H an order under another contract?
Yes. SPE2DR26FQP3H is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP3H competed?
The extent of competition for SPE2DR26FQP3H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award